81qd is an advanced data analytics company that provides global life sciences organizations with customized, high-value, cost-effective solutions designed to maximize the commercial potential of their brands through all stages of product development and commercialization.
The company’s proprietary machine learning platforms harness the power of health care encounter data to generate sophisticated analytics that identify the most influential health care professionals and their clinical networks. 81qd’s clients leverage the customized, brand-specific output to accelerate product adoption, improve sales effectiveness, enhance market access, and increase sales volume.
81qd is also at the forefront of rare disease analytics, serving as a catalyst to the earlier identification and diagnosis of patients with rare diseases.
In a highly competitive and regulated industry, 81qd’s stakeholder management products and services maximize the value of engagements, while ensuring activities are compliant on a global scale, at both the brand and enterprise level.
Our name, 81qd, comes from the smallest effective dosage of aspirin for preventing heart attack and stroke—81 mg every day—and it exemplifies our mission of providing high-value, cost-effective solutions.